Literature DB >> 16195787

Possible association between phages, Hoc protein, and the immune system.

K Dabrowska1, K Switała-Jeleń, A Opolski, A Górski.   

Abstract

Mammals have become "an environment" for enterobacterial phage life cycles. Therefore it could be expected that bacteriophages adapt to them. This adaptation must comprise bacteriophage proteins. Gp Hoc seems to have significance neither for phage particle structure nor for phage antibacterial activity. It is evidently not necessary for the "typical" antibacterial actions of bacteriophages. But the rules of evolution make it improbable that gp Hoc really has no function, and non-essential genes of T4-type phages are probably important for phages' adaptation to their particular lifestyle. More interesting is the eukaryotic origin of gp Hoc: a resemblance to immunoglobulin-like proteins that reflects their evolutionary relation. Substantial differences in biological activity between T4 and a mutant that lacks gp Hoc were observed in a mammalian system. Hoc protein seems to be one of the molecules predicted to interact with mammalian organisms and/or modulate these interactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195787     DOI: 10.1007/s00705-005-0641-7

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  Structure of the three N-terminal immunoglobulin domains of the highly immunogenic outer capsid protein from a T4-like bacteriophage.

Authors:  Andrei Fokine; Mohammad Z Islam; Zhihong Zhang; Valorie D Bowman; Venigalla B Rao; Michael G Rossmann
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters.

Authors:  Jeremy J Barr; Rita Auro; Nicholas Sam-Soon; Sam Kassegne; Gregory Peters; Natasha Bonilla; Mark Hatay; Sarah Mourtada; Barbara Bailey; Merry Youle; Ben Felts; Arlette Baljon; Jim Nulton; Peter Salamon; Forest Rohwer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-10-19       Impact factor: 11.205

Review 3.  Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.

Authors:  Abigail R Basson; Minh Lam; Fabio Cominelli
Journal:  Gastroenterol Clin North Am       Date:  2017-12       Impact factor: 3.806

Review 4.  Molecular architecture of tailed double-stranded DNA phages.

Authors:  Andrei Fokine; Michael G Rossmann
Journal:  Bacteriophage       Date:  2014-02-21

Review 5.  Movers and shakers: influence of bacteriophages in shaping the mammalian gut microbiota.

Authors:  Susan Mills; Fergus Shanahan; Catherine Stanton; Colin Hill; Aidan Coffey; R Paul Ross
Journal:  Gut Microbes       Date:  2012-09-28

Review 6.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

Review 7.  Bacteriophage T4 nanoparticles for vaccine delivery against infectious diseases.

Authors:  Pan Tao; Jingen Zhu; Marthandan Mahalingam; Himanshu Batra; Venigalla B Rao
Journal:  Adv Drug Deliv Rev       Date:  2018-07-06       Impact factor: 15.470

8.  The effects of staphylococcal bacteriophage lysates on cancer cells in vitro.

Authors:  Krystyna Dabrowska; Grzegorz Skaradziński; Aneta Kurzepa; Barbara Owczarek; Maciej Zaczek; Beata Weber-Dabrowska; Joanna Wietrzyk; Magdalena Maciejewska; Paulina Budynek; Andrzej Górski
Journal:  Clin Exp Med       Date:  2009-09-25       Impact factor: 3.984

9.  Real-Time qPCR as a Method for Detection of Antibody-Neutralized Phage Particles.

Authors:  Anna Kłopot; Adriana Zakrzewska; Dorota Lecion; Joanna M Majewska; Marek A Harhala; Karolina Lahutta; Zuzanna Kaźmierczak; Łukasz Łaczmański; Marlena Kłak; Krystyna Dąbrowska
Journal:  Front Microbiol       Date:  2017-11-06       Impact factor: 5.640

10.  Means to Facilitate the Overcoming of Gastric Juice Barrier by a Therapeutic Staphylococcal Bacteriophage A5/80.

Authors:  Ryszard Międzybrodzki; Marlena Kłak; Ewa Jończyk-Matysiak; Barbara Bubak; Anna Wójcik; Marta Kaszowska; Beata Weber-Dąbrowska; Małgorzata Łobocka; Andrzej Górski
Journal:  Front Microbiol       Date:  2017-03-23       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.